Clonal architecture ofCXCR4WHIM-like mutations in Waldenström Macroglobulinaemia-Reference-Cited by-同舟云学术

Clonal architecture ofCXCR4WHIM-like mutations in Waldenström Macroglobulinaemia

Published:2015-12-13 Issue:5 Volume:172 Page:735-744
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Xu Lian¹,Hunter Zachary R.¹²,Tsakmaklis Nicholas¹,Cao Yang¹²,Yang Guang¹²,Chen Jie¹,Liu Xia¹²,Kanan Sandra¹,Castillo Jorge J.¹²,Tai Yu-Tzu²³,Zehnder James L.⁴,Brown Jennifer R.²⁵,Carrasco Ruben D.²⁵,Advani Ranjana⁶,Sabile Jean M.⁶,Argyropoulos Kimon⁷,Lia Palomba M.⁷,Morra Enrica⁸,Trojani Alessandra⁸,Greco Antonino⁸,Tedeschi Alessandra⁸,Varettoni Marzia⁹¹⁰,Arcaini Luca⁹¹⁰,Munshi Nikhil M.²³,Anderson Kenneth C.²³,Treon Steven P.¹²

Affiliation:

1. Bing Center for Waldenström's Macroglobulinemia; Dana Farber Cancer Institute; Boston MA USA

2. Department of Medicine; Harvard Medical School; Boston MA USA

3. Lipper Center for Multiple Myeloma; Dana Farber Cancer Institute; Boston MA USA

4. Department of Pathology; Stanford University Medical Center; Stanford CA USA

5. Department of Medical Oncology; Dana Farber Cancer Institute; Boston MA USA

6. Department of Medical Oncology; Stanford University Medical Center; Stanford CA USA

7. Department of Medical Oncology; Memorial Sloane Kettering Cancer Center; New York NY USA

8. Haematology Unit; Niguarda Hospital; Milan Italy

9. Department of Molecular Medicine; University of Pavia; Pavia Italy

10. Department of Haematology Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

Funder

International Waldenstrom's Macroglobulinemia Foundation

Linda and Edward Nelson Fund

Coyote Fund

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13897/fullpdf

Reference21 articles.

1. Distinctive clinical and histological features of Waldenstrom's Macroglobulinemia and splenic marginal zone lymphoma;Arcaini;Clinical Lymphoma Myeloma Leukemia,2011

2. The WHIM-like CXCR4S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia;Cao;Leukemia,2015

3. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome;Dotta;Current Molecular Medicine,2011

4. The genomic landscape of Waldenstöm's Macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis;Hunter;Blood,2014

5. MYD88 L265P is a marker highly characteristic of, but not restricted to Waldenström's macroglobulinemia;Jiménez;Leukemia,2013

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoglobulin class‐switch recombination: Mechanism, regulation, and related diseases;MedComm;2024-08

2. Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems.;Mediterranean Journal of Hematology and Infectious Diseases;2024-06-29

3. Optimizing BTK Inhibition in Waldenström Macroglobulinemia;Journal of the National Comprehensive Cancer Network;2024-05

4. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience;Annals of Hematology;2024-04-30

5. Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia;Blood Advances;2024-04-27